Investigational Site Number :1560034

Nanjing 210009

1 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Type 1 Diabetes Mellitus

Studies at this site

• A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes — Recruiting now
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation — Completed